Global CDMO company combines DSM Pharmaceutical Products and Patheon Heerlen, Netherlands, 22-11-2013 — /EuropaWire/ — JLL Partners (“JLL”), a leading middle-market private equity firm, and Royal DSM, the global Life Sciences and Materials Sciences company, today announced the creation of a new … Read the full press release
Posted in Business, Chemicals, Financial, Healthcare, Investment, Netherlands, Science
Tagged active substances, Allen & Overy and Hinckley, Allen & Snyder LLP, Cleary Gottlieb Steen & Hamilton LLP, contract development and manufacturing organization, DSM Pharmaceutical Products, Feike Sijbesma, finished dosage, J.P. Morgan, Jefferies, Jim Mullen, JLL Partners, KeyBank, Latham & Watkins LLP, Morgan Stanley, Norton Rose Fulbright Canada LLP, Patheon, Paul S. Levy, Royal DSM, Stefan Doboczky, UBS
Key deliverable of Falsified Medicines Directive achieved 22-4-2013 — /europawire.eu/ — The European Medicines Agency has upgraded its EudraGMP database so that it now contains information on good distribution practice (GDP) in addition to good manufacturing practice (GMP). The new database, now called EudraGMDP, is a … Read the full press release
Posted in European Union, Government, Healthcare, Internet & Online, Pharma & Biotech, Technology
Tagged active substances, distributors, EudraGMDP, EudraGMP, European Falsified Medicines Directive, Falsified Medicines Directive, GDP, GDP certificates, GMP, good distribution practice, good manufacturing practice, importers, manufacturers, medicines, medicines regulatory authorities, statements of non-compliance with GDP, suppliers, The European Medicines Agency
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions.
HOW TO GET STARTED?
PHARMA & BIOTECH: The largest repository of EU/European pharma & biotech press releases spanning 12 years (2012-2024)
